Osteoarthritis (OA) is a debilitation condition affecting millions of Americans. It is a major cause of disability and is associated with pain and decreased physical function. Effective treatments to delay the progression of OA or treat the symptoms of OA are rare. Currently, conventional conservative interventions are often not effective in preventing the progression of OA or providing long‐term improvements in pain and function. But ortho-biologics is becoming a popular treatment option in OA and a variety of musculoskeletal conditions because it contains an abundance of growth factors, cytokines and/or mesenchymal progenitor cells to modulate the pathogenesis of osteoarthritis.
During this webinar, Special guest speaker, Dr. Ken Mautner will share his experiences with bone marrow and adipose prepared products to treat knee OA. In addition to protocols, outcomes, and the latest reports. Our webinar host, Dr. Peter Everts, will discuss the essential biological treatment options for OA, focusing on PRP, mesenchymal stem cell preparations from bone marrow and adipose tissue.